Abstract: This air pump device is provided with: an electric pump unit including a pump mechanism and a motor; a case; and a vibration-proof member. The pump mechanism and the motor are arranged side by side in the axial direction of the motor. The pump mechanism has an inlet and an outlet at an end in the axial direction on the opposite side of the motor. The case has a first wall and a second wall which are located on opposite sides in the axial direction of the motor and which face the electric pump unit. The vibration-proof member is provided with: a first axial vibration-proof unit interposed between the electric pump unit and the first wall; and a second axial vibration-proof unit interposed between the electric pump unit and the second wall. The first axial vibration-proof unit covers the inlet.

Abstract: A coil component includes a drum core including a winding core portion and a flange portion disposed on an end portion thereof the winding core portion in its axial direction, a planar core having a lower principal surface, and a wire wound around the winding core portion. The flange portion includes an inner end surface, an outer end surface, a bottom surface, and a top surface. The inner end surface positions the end portion of the winding core portion. The bottom surface links the inner end surface and the outer end surface and placed so as to face a mounting substrate side when being mounted. The lower principal surface of the planar core is fixed to the top surface with an adhesive interposed therebetween. The top surface includes a protrusion with a vertex positioned closer to the inner end surface than to the outer end surface.

Abstract: Provided are methods of preventing, delaying, mitigating, reducing and/or inhibiting alpha-synuclein aggregates in the brains of a subject at risk of developing or suffering a cognitive disease associated with, caused and/or mediated at least in part by alpha-synuclein aggregates, for example, Parkinson's Disease or Dementia with Lewy Bodies (DLB).

Abstract: A vacuum pump includes a pump main body and a sound muffling device. The pump main body includes a housing including an intake port and an exhaust port, and a rotor that is rotatably arranged inside the housing and transports gas from the intake port to the exhaust port. The sound muffling device includes a casing, a first passage portion, and a second passage portion. The casing includes an opening end portion that is airtightly connected to an outer wall surface of the housing, a bottom wall portion that faces the opening end portion, and a peripheral wall portion, the casing defining an expansion chamber by the outer wall surface of the housing and respective inner wall surfaces of the bottom wall portion and the peripheral wall portion.

Abstract: A vacuum pump according to an embodiment of the present invention includes a pump housing and a cooling pipe. The pump housing is constituted by cast iron. The cooling pipe includes an outer circumferential surface and an inner circumferential surface and is constituted by stainless steel. The cooling pipe passes through the pump housing and the outer circumferential surface which is in close contact with the pump housing, is constituted by a sensitized layer. This vacuum pump is formed such that the pump housing constituted by cast iron is casted around the cooling pipe constituted by stainless steel. The sensitized layer is provided on the outer circumferential surface of the cooling pipe, the sensitized layer is in contact with the pump housing, and the pump housing is efficiently cooled.

Abstract: This preventive or therapeutic agent for inflammatory diseases or bone diseases, and this pharmaceutical composition for preventing or treating inflammatory diseases or bone diseases include, as effective components, a compound represented by formula (1) or a pharmaceutically acceptable salt thereof. [In formula (1), X is a hydrogen atom, a halogen atom, or a C1-C10 alkyl group that may be substituted; R1 is a C1-C10alkyl group that may be substitute, a C1-C10alkenyl group that may be substituted, or a C6-C14 aryl group that may be substituted; and one or more hydrogen atoms may be substituted with deuterium atoms.

Abstract: The present invention is to provide a preventive or therapeutic agent for a neurodegenerative disease or a cognitive dysfunction, containing a compound represented by a following formula (I) or a pharmacologically acceptable salt thereof as an active ingredient.

Abstract: A vehicle seat device includes a fixed base, a movable base, a paddle, and an air pack. When a side airbag arranged in the seat is deployed, the expanding side airbag presses and pivots the movable base and allows for a deployment of the side airbag. The paddle is configured to change a seat support form when pressed and pivoted by the air pack. The movable base pivots about a first pivot axis relative to the fixed base. The paddle pivots about a second pivot axis relative to the movable base. The first pivot axis and the second pivot axis are arranged at different locations.

Abstract: An inlet-outlet valve device includes a main body configured in such a manner that an air tube having an air flow passage is coupled to the main body and a first securing portion and a second securing portion secured to a retaining member located inside a seat. The first securing portion is secured to a first position on the retaining member with a first securing portion fastening member. The second securing portion is secured to a second position on the retaining member via a second securing portion fastening member. The second securing portion includes an insertion hole through which the second securing portion fastening member is inserted. The insertion hole is an elongated hole extending in a direction that connects the first securing portion and the second securing portion to each other.

Abstract: Provided is a seatback rotating device. The seatback rotating device includes an electric motor and an application mechanism. The electric motor generates a rotational force that is used to rotationally displace a seatback of a vehicle seat. The application mechanism enables application of the rotational force to the seatback. The application mechanism has a configuration that enables the seatback to be self-rotatable with gravity applied to the seatback in response to the rotational force being applied to the seatback.

Abstract: Provided is a seatback rotating device used for a vehicle seat. The seatback rotating device includes an electric motor, an action mechanism, a rotor, and an abutment target portion. In the seatback rotating device, when s seatback of the vehicle sat is placed in a first standing position, the rotor is positioned in a standby state that creates a gap between a first protrusion and the abutment target portion and a gap between a second protrusion and the abutment target portion, the first protrusion and the second protrusion being provided to the rotor. In the standby state, a gap length from the first protrusion to the abutment target portion is small relative to a gap length from the second protrusion to the abutment target portion.

Abstract: A vacuum pump according to an embodiment of the present invention includes a pump housing and a cooling pipe. The pump housing is constituted by cast iron. The cooling pipe includes an outer circumferential surface and an inner circumferential surface and is constituted by stainless steel. The cooling pipe passes through the pump housing and the outer circumferential surface which is in close contact with the pump housing, is constituted by a sensitized layer. This vacuum pump is formed such that the pump housing constituted by cast iron is casted around the cooling pipe constituted by stainless steel. The sensitized layer is provided on the outer circumferential surface of the cooling pipe, the sensitized layer is in contact with the pump housing, and the pump housing is efficiently cooled.

Abstract: A vacuum pump according to an embodiment of the present invention includes a pump main body and a sound muffling device. The pump main body includes a housing including an intake port and an exhaust port, and a rotor that is rotatably arranged inside the housing and transports gas from the intake port to the exhaust port. The sound muffling device includes a casing, a first passage portion, and a second passage portion. The casing includes an opening end portion that is airtightly connected to an outer wall surface of the housing, a bottom wall portion that faces the opening end portion, and a peripheral wall portion, the casing defining an expansion chamber by the outer wall surface of the housing and respective inner wall surfaces of the bottom wall portion and the peripheral wall portion. The first passage portion is provided in the casing and introduces gas into the expansion chamber, the gas being discharged from the exhaust port.

Abstract: A vehicle seat device includes a reproduction control portion configured to inflate an airbag provided in a seat based on an internal pressure target value, an occupant detection portion configured to detect a seated state in which an occupant is seated on the seat, a body size detection portion configured to detect a size of the occupant, and a correction amount calculation portion configured to calculate, based on the size of the occupant, a correction amount to be used to correct the internal pressure target value in a non-seated state in which the occupant is not seated on the seat.

Abstract: Provided is a novel compound having rapid and long-lasting therapeutic effects on diseases exhibiting depressive symptoms. Specifically, provided are an agent for prevention and/or treatment of a depressive symptom, consisting of R(?)-ketamine or a pharmacologically acceptable salt thereof, and a pharmaceutical composition for prevention and/or treatment of a depressive symptom, comprising R(?)-ketamine or a pharmacologically acceptable salt thereof in an effective amount for reducing a depressive symptom, and being substantially free of S(+)-ketamine, and a pharmacologically acceptable salt thereof.

Abstract: The present invention provides a method for producing a container for foods which can suppress occurrences of wrinkles and blisters, and can produce a container for foods having depth and being excellent in heat insulating properties, with the use of a supercritical injection molding method. The method for producing the container for foods according to the present invention is a method for producing the container having depth, by injection molding a molten resin that contains a supercritical fluid and a resin composition, into a cavity in a metal mold, wherein the cavity includes a first region that forms an underside portion of the container for foods having depth, a second region that forms a curved side portion, and a third region that forms a lateral side portion, from a resin injection port toward a flow end, and wherein the mold surfaces that face the cavity of the second region and the third region have an arithmetic mean roughness of 0.

Abstract: A radial tire for an aircraft, the radial tire having a rim diameter of 20 inches or less includes a pair of bead portions; a pair of sidewall portions extending outward from the bead portions in a substantially radial direction; a tread portion that couples together respective radial outer ends of the sidewall portions; a toroidal carcass layer reinforcing a portion between bead cores embedded in the bead portions; a belt layer and a tread that are sequentially laminated on an outer side of the carcass layer in the radial direction, wherein a value M obtained by dividing a tire external diameter D by a distance L between bead heels of the bead portions is in a range of from 4.1 to 5.4.

Abstract: A pneumatic pressure control method for a vehicle seat includes: repeatedly detecting an internal pressure of a bladder provided inside the vehicle seat at intervals; correcting the internal pressure of the bladder based on a differential pressure between a detection value and a target value; and lengthening a detection interval to detect the internal pressure depending on a time elapsing from starting of the vehicle.

Abstract: Provided is a novel compound having rapid and long-lasting therapeutic effects on diseases exhibiting depressive symptoms. Specifically, provided are an agent for prevention and/or treatment of a depressive symptom, consisting of R(?)-ketamine or a pharmacologically acceptable salt thereof, and a pharmaceutical composition for prevention and/or treatment of a depressive symptom, comprising R(?)-ketamine or a pharmacologically acceptable salt thereof in an effective amount for reducing a depressive symptom, and being substantially free of S(+)-ketamine, and a pharmacologically acceptable salt thereof.

Abstract: To provide: an agent for the prevention and/or treatment of a depressive symptom, the drug consisting of (S)-norketamine or a pharmacologically acceptable salt thereof; a pharmaceutical composition for the prevention and/or treatment of a depressive symptom, the pharmaceutical composition containing (S)-norketamine or a pharmacologically acceptable salt thereof in an amount effective for alleviation of the depressive symptom, and being substantially free of (R)-norketamine; a method for the prevention and/or treatment of a depressive symptom, the method including administration of the drug or the composition; and use of (S)-norketamine for production of a drug for the prevention and/or treatment of a depressive symptom or a composition for the prevention and/or treatment of a depressive symptom.